CAVE CREEK, AZ – March 31, 2014 -- Endexx Corporation (OTC Pink: EDXC) announces the establishment of new medical marijuana consumable division dedicated to the development and marketing of medical grade CBD infused “cannsumables”. Endexx will refer to our products by the proprietary names: “cannsumer good(s), cannsumable(s), and cannsumer(s)”.
The new division will focus on edible delivery systems for alternative medical applications of cannabidiol extracts in the form of CBD infused “cannsumer goods” for the legal medical marijuana market. The product line will further complement m3hub’s existing line of technologies and services in its mission to:
• Facilitate all transactions with concentric care to the patient in the clinical environment of pain management and long term chronic care.
• Bring pharmacy grade compliance and standardized technology solutions to the Medical Marijuana Industry
Cannabidiol (CBD) is a non-psychoactive natural compound that has been shown in scientific and clinical studies to possess beneficial properties in the treatment of a wide range of conditions including among others arthritis, diabetes, MS, PTSD, skin cancer, epilepsy, seizures and other neurological disorders.
During the last month alone, traditionally conservative states like Alabama, Georgia, Tennessee, South Carolina, North Carolina, Kentucky, Indiana, Wisconsin, Utah and Florida, have come to recognize the medical benefits of marijuana and its active compounds. Even though none of these states have to date supported the legalization of medical marijuana, they all have recently introduced or passed bills to legalize the use of CBD in the treatment of epilepsy and other debilitating conditions.
In anticipation of a growing demand from alternative therapy patients for diverse delivery methods, Endexx is in the process of establishing the necessary framework for the successful deployment of the new medical marijuana consumable division:
• Endexx is negotiating the acquisition of facilities for the production of medical grade cannabidiol infused products.
• Endexx is securing access to legally produced CBD extracts and base products.
• Endexx is also identifying and engaging with critical collaboration partners with expertise in the fields of food manufacturing, botanicals, bio-remedies and nutraceuticals.
Todd Davis, Endexx CEO stated: ”Endexx will develop and produce the CBD infused “cannsumables” using state of the art facilities and technology that meets or exceeds ISO 9000 standards to ensure guaranteed potency and consistent quality of the end product. We are mandating policies that offer the safest, highest quality products with lower than average operating costs which will directly translate into increased shareholder value.”
About Endexx :
www.endexx.com www.gsgsolar.com www.m3hub.com www.autospense.com
Endexx Corporation is a micro-cap publicly traded company, representing the interest of its shareholders and collaborating with independent software engineers and architects, scientists, engineers, and other companies to build businesses that can thrive collectively in the equity markets. The Endexx team recognizes that individually small companies with new technologies have an extremely difficult time sustaining themselves as stand-alone companies. Through our collaborative practices, individual and group skill sets are better utilized to develop technology and grow the business, while centralizing costs and eliminating redundancies.
The Endexx management team and its advisory group each have at minimum 10-50 years of experience in their respective fields. The business professionals associated with the direction of the company all have experience growing businesses, developing and implementing new technologies and running publicly traded corporations.
Endexx Corporation is ultimately structured to provide a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each individual is a shareholder and is encouraged and self-driven to be successful and contribute to the overall objective of increasing shareholder value.
Contact Endexx via email to receive corporate news and updates at Endexx@endexx.com.
Safe Harbor Notice: This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
M3Hub Sales: 480-999-0097
Irth Communications, LLC.